Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Sangamo Therapeutics (SGMO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,500,230
  • Shares Outstanding, K 84,520
  • Annual Sales, $ 19,390 K
  • Annual Income, $ -71,660 K
  • 36-Month Beta 3.16
  • Price/Sales 40.82
  • Price/Cash Flow N/A
  • Price/Book 7.84

Price Performance

See More
Period Period Low Period High Performance
1-Month
15.65 +13.42%
on 12/20/17
19.50 -8.97%
on 01/16/18
+1.80 (+11.29%)
since 12/19/17
3-Month
11.30 +57.08%
on 10/26/17
19.50 -8.97%
on 01/16/18
+3.80 (+27.24%)
since 10/19/17
52-Week
3.35 +429.85%
on 01/31/17
19.50 -8.97%
on 01/16/18
+13.80 (+349.37%)
since 01/19/17

Most Recent Stories

More News
Sangamo Therapeutics Outlines 2018 Key Priorities And Catalysts At J.P. Morgan Healthcare Conference

In meetings with investors this week and during a presentation Wednesday at the J.P. Morgan Healthcare Conference in San Francisco, Sangamo Therapeutics, Inc. (NASDAQ: SGMO) Chief Executive Officer, Dr....

SGMO : 17.75 (+1.43%)
20.8% Return Seen to Date on SmarTrend Sangamo Therapeu Call (SGMO)

SmarTrend identified an Uptrend for Sangamo Therapeu (NASDAQ:SGMO) on November 15th, 2017 at $14.28. In approximately 2 months, Sangamo Therapeu has returned 20.84% as of today's recent price of $17.25....

SGMO : 17.75 (+1.43%)
Sangamo Therapeutics To Present At The 36th Annual J.P. Morgan Healthcare Conference

Sangamo Therapeutics, Inc. (NASDAQ: SGMO) announced today that Dr. Sandy Macrae, CEO of Sangamo, will present at the 36th Annual J.P. Morgan Healthcare Conference on Wednesday, January 10th at 4:00 p.m....

SGMO : 17.75 (+1.43%)
JPM : 113.01 (-0.22%)
Pfizer (PFE) Collaborates With Sangamo for Gene Therapy

Pfizer entered into collaboration agreements with Sangamo Therapeutics and private biotech, Arvinas.

SGMO : 17.75 (+1.43%)
XOMA : 33.58 (+1.30%)
EXEL : 28.00 (+0.50%)
PFE : 36.94 (-0.14%)
Biotech Stock Roundup: GWPH Submits Epidiolex in the EU, Sangamo Inks Deal with Pfizer

Collaboration agreements announced by companies like Sangamo (SGMO) and the submission of a regulatory application for GW's Epidiolex were the key highlights this week in the biotech sector.

SGMO : 17.75 (+1.43%)
LGND : 155.81 (+3.49%)
ONCE : 51.26 (+1.40%)
GWPH : 132.42 (+0.33%)
SGEN : 53.48 (+0.06%)
UTHR : 139.51 (-0.01%)
BIIB : 342.41 (-0.59%)
Sangamo and Pfizer announce collaboration for development of zinc finger protein gene therapy for ALS

Sangamo Therapeutics, Inc. (Nasdaq: SGMO) and Pfizer Inc. (NYSE: PFE) today announced a collaboration for the development of a potential gene therapy using zinc finger protein transcription factors (ZFP-TFs)...

SGMO : 17.75 (+1.43%)
PFE : 36.94 (-0.14%)
Uptrend Call Working As Sangamo Therapeu Stock Rises 19.4% (SGMO)

SmarTrend identified an Uptrend for Sangamo Therapeu (NASDAQ:SGMO) on November 15th, 2017 at $14.28. In approximately 1 month, Sangamo Therapeu has returned 19.44% as of today's recent price of $17.05....

SGMO : 17.75 (+1.43%)
The Zacks Analyst Blog Highlights: ACADIA Pharmaceuticals, Sangamo Therapeutics, AnaptysBio and Sino Biopharmaceutical

The Zacks Analyst Blog Highlights: ACADIA Pharmaceuticals, Sangamo Therapeutics, AnaptysBio and Sino Biopharmaceutical

SGMO : 17.75 (+1.43%)
ANAB : 114.91 (+4.04%)
ACAD : 26.92 (-3.10%)
SBMFF : 1.9250 (+6.94%)
5 of the Best-Performing Biotech Stocks of 2017

With 2017 coming to an end, it is time to take a look at the performance of the biotech sector and some of the best-performing biotech stocks including XOMA (XOMA).

SGMO : 17.75 (+1.43%)
XOMA : 33.58 (+1.30%)
BLUE : 175.95 (-3.38%)
ALNY : 124.83 (+0.68%)
DVAX : 15.65 (+1.46%)
GILD : 80.98 (-0.23%)
PFE : 36.94 (-0.14%)
4 Biotech Stocks Ready to Crush the Market in 2018

The biotech sector has performed well in 2017 and we expect the momentum to continue in 2018 driven by new drug approvals. Here, we list stocks which might be worth adding to your biotech portfolio for...

SGMO : 17.75 (+1.43%)
ANAB : 114.91 (+4.04%)
CELG : 102.65 (+0.91%)
GILD : 80.98 (-0.23%)
ACAD : 26.92 (-3.10%)
SBMFF : 1.9250 (+6.94%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Average. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Sangamo Therapeutics, Inc. is a biotechnology company. It focuses on research and development of genomic therapies as well as develops medicines for patient with genetic diseases. The Company's product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. Sangamo Therapeutics Inc.,...

See More

Key Turning Points

2nd Resistance Point 18.22
1st Resistance Point 17.99
Last Price 17.75
1st Support Level 17.51
2nd Support Level 17.26

See More

52-Week High 19.50
Last Price 17.75
Fibonacci 61.8% 13.33
Fibonacci 50% 11.43
Fibonacci 38.2% 9.52
52-Week Low 3.35

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.